Background: DNA hypermethylation induces cancer progression involving CpG island of DNA and causes inactivation of tumour suppressor genes. In this study, DNA hypermethylation status of lung cancer and ability of ultra-highly diluted Condurango 30C to modulate DNA methylation were ascertained by analysis of lung cancer-specific tumour suppressor genes in respect to placebo. Materials and Methods: DNA methylation status, if any, was determined by PCR-SSCP analyses in lung cancer-specific tumour suppressor genes (p15, p16 and p53) using H460-NSCLC cell and BaP-induced lung cancer of rats. The ability of Condurango 30C to modulate DNA methylation, if any, was verified against placebo control in blinded manner. Results: Condurango 30C-treated DNA showed significant decrease in band intensity of p15 and p53 genes especially in methylated condition in vitro, at IC50 dose (2.43µl/100µl). SSCP analysis of p15 and p53 genes in Condurango 30C-treated DNA also suggests that Condurango 30C can decrease methylation, in vitro. Inhibition of p15 hypermethylation was observed in post-cancer treatment of rats with Condurango 30C. SSCP results gave a better indication of differences in band position of p15 and p53 in Condurango 30C-treated lung samples. Conclusion: Condurango 30C could trigger epigenetic modification in lung cancer via modulation of DNA hypermethylation.

Journal Section:
Original Article · Originalarbeit
Keywords:
DNA methylation, CpG islands, Epigenetic modification, Condurango 30C, Lung cancer, PCR-SSCP analysis, Homeopathy
1.
Paz MF, Fraga MF, Avila S, et al.: A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 2003;63:1114-1121.
2.
Ke D, Bo L, Yang Q, et al.: Aberrant methylation in CpG islands of p15 and p16 tumor suppressor genes in pancreatic cancer tissue. The Chinese-German Journal of Clinical Oncology 2005;4:213-217.
3.
Esteller M, Tortola S, Toyota M, et al.: Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 2000;60:129-133.
4.
Laird PW, Jaenisch R: DNA methylation and cancer. Hum Mol Genet 1994;1487-1495.
5.
Meng HX, Hackett JA, Nestor C, et al.: Apoptosis and DNA methylation. Cancer 2011;3:1798-1820.
6.
Kassab S, Cummings M, Berkovitz S, et al.: Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev 2009;2:CD004845.
7.
Fisher P: The information medicine hypothesis; in Shulte J, Endler PC, (ed): Fundamental Research in Ultra High Dilution and Homoeopathy. Dordrecht, Kluwer, 1998, pp xi-xiv.
8.
The HomBRex database 2012. www.carstens-stiftung.de/hombrex/index.php (accessed 27.05.2015).
9.
Bhattacharyya SS, Paul S, Khuda-Bukhsh AR: Encapsulated plant extract (Gelsemium sempervirens) poly (lactide-co-glycolide) nanoparticles enhance cellular uptake and increase bioactivity in vitro. Exp Biol Med (Maywood) 2010;235:678-688.
10.
Bell IR, Koithan M: A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system. BMC Complement Altern Med 2012;12:191.
11.
Chikramane PS, Suresh AK, Bellare JR, et al.: Extreme homeopathic dilutions retain starting materials: a nanoparticulate perspective. Homeopathy 2010;99:231-242.
12.
Bellavite P, Marzotto M, Olioso D, et al.: High-dilution effects revisited. 1. Physicochemical aspects. Homeopathy 2014;103:4-21.
13.
Bellavite P, Fisher P: Homeopathy: Where is the bias? Eur J Intern Med 2014;25:e66.
14.
Khuda-Bukhsh AR: Alteration of X-ray effects by homeopathic drugs: a new approach in radio-protection; in Manna GK, Roy SC (eds): Perspectives in Cytology and Genetics, vol. 8. New Delhi, All India Congress of Cytology and Genetics, 1995, pp 649-663.
15.
Khuda-Bukhsh AR: Potentized homeopathic drugs act through regulation of gene expression: a hypothesis to explain their mechanism and pathways of action in vivo. Complement Ther Med 1997;5:43-46.
16.
Sikdar S, Mukherjee A, Bishayee K, et al.: Post-cancer treatment with Condurango 30C shows amelioration of benzo(a)pyrene-induced lung cancer of rats through caspase-3 mediated apoptosis induction. J Pharmacopuncture 2013;16:11-22.
17.
Sikdar S, Khuda-Bukhsh AR: Post-cancer treatment of Condurango 30C, traditionally used in homeopathy, ameliorates tissue damage and stimulates reactive oxygen species in benzo(a)pyrene-induced lung cancer of rat. TANG (Humanitus traditional medicine) 2013;3:e25.
18.
Sikdar S, Mukherjee A, Ghosh S, Khuda-Bukhsh AR: Condurango glycoside-rich components stimulate DNA damage-induced cell cycle arrest and ROS-mediated caspase-3 dependent apoptosis through inhibition of cell-proliferation in lung cancer, in vitro and in vivo. Environ Toxicol Pharmacol 2014;37:300-314.
19.
Sikdar S, Saha SK, Khuda-Bukhsh AR: Relative apoptosis-inducing potential of homeopathic Condurango 6C and 30C in H460 lung cancer cells in vitro: the signaling cascade. J Pharmacopuncture 2014;17:59-69.
20.
Bishayee K, Sikdar S, Khuda-Bukhsh AR: Evidence of an epigenetic modification in cell-cycle arrest caused by the use of ultra-highly-diluted Gonolobus Condurango extract. J Pharmacopuncture 2013;16:7-13.
21.
Dong K, Li B, Qing Y, et al.: Aberrant methylation in CpG islands of p15 and p16 tumor suppressor genes in pancreatic cancer tissue. The Chinese-German Joural of Clinical Oncology 2005;4:213-217.
22.
Ye Y, Wang D, Su C, et al.: Combined detection of p53, p16, Rb, and EGFR mutations in lung cancer by suspension microarray. Genet Mol Res 2009;8:1509-1518.
23.
Bandyopadhyay S, Bera AK, Sikdar S, et al.: Intra-species sequence variability in 28s rRNA gene of Oesophagostomum venulosum isolated from goats of West Bengal, India. Asian Pacific Journal of Tropical Medicine 2010;515-518.
24.
Paul S, Bhattacharyya SS, Samaddar A, et al.: Anticancer potentials of root extract of Polygala senega against benzo(a)pyrene-induced lung cancer in mice. Zhong Xi Yi Jie He Xue Bao 2011;9:320-327.
25.
Biswas SJ, Khuda-Bukhsh AR: Effect of a homeopathic drug, Chelidonium, in amelioration of p-DAB induced hepatocarcinogenesis in mice. BMC Complement Altern Med 2002;2:4.
26.
Tsou HR, Overbeek-Klumpers EG, Hallett WA, et al.: Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. J Med Chem 2005;48:1107-1131.
27.
Khuda-Bukhsh AR: Towards understanding molecular mechanisms of action of homeopathic drugs: an overview. Mol Cell Biochem 2003;253:339-345.
28.
Khuda-Bukhsh AR: Laboratory research in homeopathy: pro. Integr Cancer Ther 2006;5:320-332.
29.
Khuda-Bukhsh AR: Mice as a model for homeopathy research. Homeopathy 2009;98:267-279.
© 2015 S. Karger GmbH, Freiburg
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.